Radionetics Oncology is a precision oncology company focusing on the discovery and development of radiopharmaceuticals. The company was spun out Crinetics Pharmaceuticals in 2021 with a pipeline built from Crinetics’ core non-peptide platform and includes drug candidates and leads against at
Location: United States
Employees: 11-50
Total raised: $82.5M
Founded date: 2021
Investors 2
| Date | Name | Website |
| 25.11.2021 | 5AM Ventur... | 5amventure... |
| - | Frazier Li... | frazierls.... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.01.2024 | Series A | $52.5M | - |
| 28.10.2021 | - | $30M | - |
Mentions in press and media 6
| Date | Title | Description |
| 09.01.2024 | Why Carta’s public battle might be a private markets nightmare | To say the Carta news that broke over the weekend has caused a furor in the startup world is an understatement. The accusation that the cap table management and software unicorn was using customers’ confidential data to bolster its own busi... |
| 05.01.2024 | Radionetics Oncology Closes $52.5 M Series A | SAN DIEGO, CA, Radionetics Oncology closes $52.2M Series A funding led by Frazier Life Sciences, 5AM Ventures and DCVC Bio. >> Click here for more funding data on Radionetics Oncology >> To export Radionetics Oncology fundin... |
| 03.01.2024 | Radionetics Oncology Closes $52.5M Series A Financing | Radionetics Oncology, a San Diego, CA-based clinical stage radiopharmaceutical company focused on the discovery and development of novel agents for the treatment of a wide range of oncology indications, raised $52.5M in Series A funding. Th... |
| 03.01.2024 | Radionetics Oncology Snags $52.5M | San Diego-based Radionetics Oncology, a company that is working on cancer treatments, said this morning that it has raised $52.5M in a Series A funding. The funding was led by Frazier Life Sciences, 5AM Ventures and DCVC Bio. According to R... |
| 28.10.2021 | Radionetics Oncology Launches with $30M Investment | Photo Courtesy of Crinetics San Diego-based Crinetics Pharmaceuticals focuses on discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Radionetics Oncology, a pharmaceutical c... |
| - | Radionetics Oncology | “The power to stop cancer. The experience to know how. The dedication to make a difference.” |